Candida autovaccination in the treatment of vulvovaginal Candida infections

International Journal of Gynecology and Obstetrics

Volumn 96, Issue 2, 2007, Pages 130-

  Rusch, K ^a   Schwiertz, A ^a  

^a Institute for Microecology   (Germany)

Author keywords

Autovaccine; Candida; Infection

Indexed keywords

ANTIFUNGAL AGENT; AUTOVACCINE; CANDIDA VACCINE; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; UNCLASSIFIED DRUG;

ACNE; ARTICLE; CANDIDA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; OPPORTUNISTIC INFECTION; PREVALENCE; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; SYMPTOMATOLOGY; VACCINATION; VAGINA CANDIDIASIS;

EID: 33947266549     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2006.11.003     Document Type: Article

References (4)

1. Wilson C. Recurrent vulvovaginitis candidiasis; an overview of traditional and alternative therapies. Adv Nurse Pract 13 5 (May 2005) 24-29
2. Wright A.E. On therapeutic inoculations of bacterial vaccines, and their practical exploitation in the treatment of disease. Br Med J (1903) 1069-1074
3. Rusch V., Ottendorfer D., Zimmermann K., Gebauer F., Schrodl W., Nowak P., et al. Results of an open, non-placebo controlled pilot study investigating the immunomodulatory potential of autovaccine. Arzneimittelforschung 51 8 (2001) 690-697
4. Zaluga E. Skin reactions to antigens of Propionibacterium acnes in patients with acne vulgaris treated with autovaccine. Ann Acad Med Stetin 44 (1998) 65-85